article thumbnail

UK agency pilots biobank to study links between genetics and drug side effects

Pharmaceutical Technology

The Medicines and Healthcare products Regulatory Agency (MHRA) aims to launch a pilot genetic biobank that will gather patient data to associate drug-related adverse events to their genetic makeup. Side effects due to drugs are responsible for one in every 16 hospital admissions in the UK, based on the announcement.

article thumbnail

Tributes as former NICE, MHRA chair Sir Mike Rawlins dies

pharmaphorum

The UK healthcare sector is mourning one of the most eminent of its figures in the last few decades – Professor Sir Mike Rawlins – who has passed away at the age of 81. ” The post Tributes as former NICE, MHRA chair Sir Mike Rawlins dies appeared first on.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Constipation Patients Are Suffering in Silence—Here’s How to Help Them

PM360

Those patients should be encouraged to talk with their healthcare providers about their chronic constipation—and the dangers of living with it, Ironwood Pharmaceuticals CEO Thomas McCourt says. Second, patients aren’t communicating clearly with their healthcare provider about their constipation symptoms. 1, 2013. References: 1.

article thumbnail

Digital Self-Neuromodulation Therapy for PTSD: Interview with Oded Kraft, CEO of GrayMatters Health

Medgadget

These treatments at times come with a long list of side effects, leaving many patients in search of an effective long-term solution. For some patients with PTSD, psychotherapy may not be an effective option, they may find talking about their traumatic experience stress inducing, untherapeutic or ineffective.

article thumbnail

Targeting tumours with novel radiopharmaceuticals

European Pharmaceutical Review

One aspect that is extremely promising about radiopharmaceutical therapeutics is that they do not give a patient the side effects that are commonly experienced with chemotherapy. Hoppin served as lead director of Noria as the two organisations were sold to Bayer Healthcare in June of 2021.